Glibenclamide (HB 419): a new oral antidiabetic of sulphonylurea type.
D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged
D007004:Hypoglycemic Agents